Mei Yin Su

age ~51

from Pittsburgh, PA

Get Report

Also known as:

Connected to:

Mei Su Phones & Addresses

Name / Title

Company / Classification

Phones & Addresses

Mei Su
Executive

Mei,su
Drinking Places (alcoholic Beverages)

816 Peninsula Ave, Chino, CA 91710

view source

view source

view source

view source

4-(3-Aminopyrazole) Pyrimidine Derivatives For Use As Tyrosine Kinase Inhibitors In The Treatment Of Cancer
view source
US Patent:

8088784, Jan 3, 2012
Filed:

Feb 26, 2010
Appl. No.:

12/713695
Inventors:

Xiaomei Feng - Waltham MA, US
Huiping Guan - Waltham MA, US
Ying Kang - Shanghai, CN
Stephanos Ioannidis - Waltham MA, US
Bo Peng - Waltham MA, US
Mei Su - Waltham MA, US
Bin Wang - Longmont CO, US
Tao Wang - Waltham MA, US
Hai-Jun Zhang - Waltham MA, US
Assignee:

AstraZeneca AB - Sodertalje
International Classification:

C07D 403/14
A61K 31/506
US Classification:

514275, 544296
Abstract:

This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

9-(Pyrazol-3-Yl)-9H-Purine-2-Amine And 3-(Pyrazol-3-Yl) -3H-Imidazo[4,5-B] Pyridin-5-Amine Derivatives And Their Use For The Treatment Of Cancer
view source
US Patent:

8486966, Jul 16, 2013
Filed:

May 2, 2008
Appl. No.:

12/598473
Inventors:

Audrey Davies - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
Michelle Lamb - Waltham MA, US
Mei Su - Waltham MA, US
Tao Wang - Waltham MA, US
Hai-Jun Zhang - Waltham MA, US
Assignee:

Astrazeneca AB - Sodertalje
International Classification:

A01N 43/42
A61K 31/44
C07D 471/02
C07D 491/02
C07D 498/02
US Classification:

514303, 546118
Abstract:

The present invention relates to compounds of Formula (I): and to their pharmaceutical compositions, and to their methods of use. These compounds provide a treatment for myeloproliferative disorders and cancer.

Substitute Thiophenes And Uses Therof
view source
US Patent:

20060281666, Dec 14, 2006
Filed:

Aug 12, 2004
Appl. No.:

10/568380
Inventors:

Susan Ashwell - Waltham, GB
Thomas Gero - Waltham MA, US
Stephanos Ioannidis - Watham MA, US
James Janetka - Waltham MA, US
Paul Lyne - Waltham MA, US
Vibha Oza - Waltham MA, US
Stephanie Springer - Cambridge MA, US
Mei Su - Waltham MA, US
Dingwei Yu - Waltham MA, US
International Classification:

A61K 31/00
US Classification:

514001000
Abstract:

This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cancer.

Novel Fused Triazolones And The Uses Thereof
view source
US Patent:

20070149560, Jun 28, 2007
Filed:

Mar 10, 2004
Appl. No.:

10/549053
Inventors:

Susan Ashwell - Waltham MA, US
Jayachandran Ezhuthachan - Waltham MA, US
Paul Lyne - Waltham MA, US
Nicholas Newcombe - Cheshire, GB
Martin Pass - Cheshire, GB
Vibha Oza - Waltham MA, US
Mei Su - Waltham MA, US
Dorin Toader - Waltham MA, US
Dingwei Yu - Waltham MA, US
Yan Yu - Waltham MA, US
Assignee:

AstraZeneca AB - Sodertalje
International Classification:

A61K 31/4745
C07D 487/02
US Classification:

514292000, 546082000
Abstract:

This invention relates to novel compounds having the structural diagram (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment or prophylaxis of cancer.

4-(3-Aminopyrazole) Pyrimidine Derivatives For Use As Tyrosine Kinase Inhibitors In The Treatment Of Cancer
view source
US Patent:

20080287475, Nov 20, 2008
Filed:

Oct 26, 2006
Appl. No.:

12/091382
Inventors:

Xiaomei Feng - Waltham MA, US
Huiping Guan - Waltham MA, US
Ying Kan - Shanghai, CN
Stephanos Ioannidis - Waltham MA, US
Bo Peng - Waltham MA, US
Mei Su - Waltham MA, US
Bin Wang - Longmont CO, US
Tao Wang - Waltham MA, US
Hai-Jun Zhang - Waltham MA, US
Assignee:

ASTRAZENECA AB - Sodrtalje
International Classification:

A61K 31/506
A61P 35/00
C07D 403/14
C07D 413/14
US Classification:

514272, 544296, 544122, 514275, 514269
Abstract:

This invention relates to novel compounds having the formula (I) and to their pharmaceutical compositions and to their methods of use. These novel compounds provide a treatment for cancer.

Substituted Thiophenes And Uses Thereof
view source
US Patent:

20090054396, Feb 26, 2009
Filed:

Sep 8, 2008
Appl. No.:

12/206317
Inventors:

Susan Ashwell - Waltham MA, US
Thomas Gero - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
James Janetka - Waltham MA, US
Paul Lyne - Waltham MA, US
Vibha Oza - Waltham MA, US
Mei Su - Waltham MA, US
Dingwei Yu - Waltham MA, US
Stephanie Springer - North Andover MA, US
Assignee:

ASTRAZENECA AB - Sodertalje
International Classification:

A61K 31/397
C07D 409/02
C07D 333/36
C07D 205/04
C07D 453/02
A61K 31/4406
A61K 31/395
A61K 31/381
A61P 35/00
A61K 31/496
A61K 31/551
C07D 243/08
C07D 221/02
C07D 401/02
US Classification:

51421019, 546213, 549 69, 5462814, 540596, 548527, 548953, 544379, 546133, 549 60, 549 59, 540575, 546112, 544405, 51421703, 514218, 51425213, 51425505, 514326, 514447, 514444, 514438
Abstract:

This invention relates to novel compounds having the structural formula (I) and to their pharmaceutical salts, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cancer.

Tricyclic 2,4-Diamino-L,3,5-Triazine Derivatives Useful For The Treatment Of Cancer And Myeloproliferative Disorders
view source
US Patent:

20110183954, Jul 28, 2011
Filed:

Dec 17, 2009
Appl. No.:

12/997054
Inventors:

Lynsie Almeida - Waltham MA, US
Claudio Edmundo Chuaqui - Waltham MA, US
Stephanos Loannidis - Waltham MA, US
Bo Peng - Waltham MA, US
Mei Su - Waltham MA, US
Assignee:

ASTRAZENECA AB - Sodertalje
International Classification:

A61K 31/397
C07D 413/14
A61K 31/5377
C07D 401/14
A61K 31/53
A61P 35/00
US Classification:

5142102, 544113, 5142362, 544216, 514245
Abstract:

The present invention relates to compounds of Formula (I): (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer.

Heterocyclic Jak Kinase Inhibitors
view source
US Patent:

20110201628, Aug 18, 2011
Filed:

Sep 29, 2009
Appl. No.:

13/119028
Inventors:

Claudio Edmundo Chuaqui - Waltham MA, US
Shan Huang - Waltham MA, US
Stephanos Ioannidis - Waltham MA, US
Jie Shi - Waltham MA, US
Mei Su - Waltham MA, US
Qibin Su - Waltham MA, US
International Classification:

A61K 31/519
C07D 491/04
C07D 487/04
C07D 471/04
C07D 239/70
C07D 239/72
A61K 31/517
A61P 35/00
US Classification:

5142601, 544278, 544280, 544255, 544253, 5142581, 5142621, 5142641, 5142651, 51426623
Abstract:

The present invention relates to compounds of Formula (I) and to their salts, pharmaceutical compositions, methods of use, and methods for their preparation. These compounds provide a treatment for myeloproliferative disorders and cancer.